8
NOV
Reports
Q3, 2023 earnings report expected
SUPN
Supernus Pharmaceuticals Inc
32.65
32.65
(0%)
EPS
$0
Estimated Sales
$0
Market Cap
$0
Trade
Mentioned
SUPN
1.44 (4.62%)
S
32.62
B
32.77
@MarketUpdates
United Kingdomabout a year ago
8
NOV
Reports
Q3, 2023 earnings report expected
SUPN
Supernus Pharmaceuticals Inc
32.65
32.65
(0%)
EPS
$0
Estimated Sales
$0
Market Cap
$0
Trade
1 Mentioned
SUPN
Supernus Pharmaceuticals Inc